Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


25.06.2018

1 Acta Neurol Scand
1 Ann Neurol
1 BMC Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
6 Mult Scler
1 Neurologia
1 Neurology
1 PLoS One
1 Rev Neurol (Paris)


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. RORSMAN I, Petersen C, Nilsson PC
    Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial.
    Acta Neurol Scand. 2018;137:117-124.
    PubMed     Text format     Abstract available


    Ann Neurol

  2. JIA X, Madireddy L, Caillier S, Santaniello A, et al
    Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
    Ann Neurol. 2018 Jun 16. doi: 10.1002/ana.25263.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. AL WUTAYD O, Mohamed AG, Saeedi J, Al Otaibi H, et al
    Environmental exposures and the risk of multiple sclerosis in Saudi Arabia.
    BMC Neurol. 2018;18:86.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  4. CHEN J, Taylor BV, Blizzard L, Simpson S Jr, et al
    Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data.
    J Neurol Neurosurg Psychiatry. 2018 Jun 19. pii: jnnp-2018-318228.
    PubMed     Text format     Abstract available


    J Neurol Sci

  5. KAWADA T
    Screening ability of cognitive function by two measures in patients with multiple sclerosis.
    J Neurol Sci. 2018 Jun 13. pii: S0022-510X(18)30258.
    PubMed     Text format    


    Mult Scler

  6. ENZINGER C
    High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - NO.
    Mult Scler. 2017 Mar 1:1352458516681505. doi: 10.1177/1352458516681505.
    PubMed     Text format    

  7. YAP SM, McGuigan C
    High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - YES.
    Mult Scler. 2017 Mar 1:1352458517697909. doi: 10.1177/1352458517697909.
    PubMed     Text format    

  8. MANOUCHEHRINIA A, Zhu F, Piani-Meier D, Lange M, et al
    Predicting risk of secondary progression in multiple sclerosis: A nomogram.
    Mult Scler. 2018 Jun 1:1352458518783667. doi: 10.1177/1352458518783667.
    PubMed     Text format     Abstract available

  9. CHEN J, Taylor B, Palmer AJ, Kirk-Brown A, et al
    Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis.
    Mult Scler. 2018 Jun 1:1352458518781971. doi: 10.1177/1352458518781971.
    PubMed     Text format     Abstract available

  10. REDDEL SW, Barnett MH, Riminton S, Dugal T, et al
    Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) study.
    Mult Scler. 2018 Jun 1:1352458518783673. doi: 10.1177/1352458518783673.
    PubMed     Text format     Abstract available

  11. AL HUSSONA M, Kearney H, Fisher A, Lynch J, et al
    New onset seizures as a sole clinical presentation of multiple sclerosis.
    Mult Scler. 2018 Jun 1:1352458518781994. doi: 10.1177/1352458518781994.
    PubMed     Text format     Abstract available


    Neurologia

  12. EICHAU S, Lopez Ruiz R, Caston Osorio JJ, Ramirez E, et al
    Primary cytomegalovirus infection in a patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab.
    Neurologia. 2018 Jun 12. pii: S0213-4853(18)30118.
    PubMed     Text format    


    Neurology

  13. HAGENS MHJ, Burggraaff J, Kilsdonk ID, de Vos ML, et al
    Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005825.
    PubMed     Text format     Abstract available


    PLoS One

  14. MAIA DINIZ I, Guerra AA Junior, Lovato Pires de Lemos L, Souza KM, et al
    The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.
    PLoS One. 2018;13:e0199446.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  15. EDAN G
    Multiple Sclerosis over the last 25 years: an introduction.
    Rev Neurol (Paris). 2018;174:353-354.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: